Stable release of BDNF from the fibroblast cell line NIH3T3 grown on silicone elastomers enhances survival of spiral ganglion cells in vitro and in vivo

Hearing Research

Volumn 289, Issue 1-2, 2012, Pages 86-97

  Warnecke, Athanasia ^a   Sasse, Susanne ^a   Wenzel, Gentiana I ^a   Hoffmann, Andrea ^a,b   Gross, Gerhard ^b   Paasche, Gerrit ^a   Scheper, Verena ^a   Reich, Uta ^c   Esser, Karl Heinz ^d   Lenarz, Thomas ^a   Stöver, Timo ^a,e   Wissel, Kirsten ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^e GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; RECOMBINANT BRAIN DERIVED NEUROTROPHIC FACTOR; SILASTIC;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL GROWTH; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; COCHLEA; COCULTURE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECT; EMBRYO; FEMALE; FIBROBLAST; GUINEA PIG; HEARING IMPAIRMENT; HUMAN; HUMAN CELL; IMPLANTATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MATERIAL COATING; MOUSE; NERVE CELL; NERVE FIBER GROWTH; NEUROPROTECTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; SPIRAL GANGLION CELL;

ANIMALS; ANIMALS, NEWBORN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL ADHESION; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELL SURVIVAL; COCULTURE TECHNIQUES; DEAFNESS; DISEASE MODELS, ANIMAL; ETHACRYNIC ACID; FEMALE; FIBROBLASTS; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; GUINEA PIGS; HUMANS; KANAMYCIN; LENTIVIRUS; MALE; MICE; NEURONS; NIH 3T3 CELLS; PARACRINE COMMUNICATION; RATS; RATS, SPRAGUE-DAWLEY; SILICONE ELASTOMERS; SPIRAL GANGLION; TIME FACTORS; TRANSFECTION;

EID: 84861893474     PISSN: 03785955     EISSN: 18785891     Source Type: Journal    
DOI: 10.1016/j.heares.2012.04.007     Document Type: Article

References (68)

1. Agterberg M.J., Versnel H., van Dijk L.M., de Groot J.C., Klis S.F. Enhanced survival of spiral ganglion cells after cessation of treatment with brain-derived neurotrophic factor in deafened guinea pigs. J. Assoc. Res. Otolaryngol. 2009, 10:355-367.
2. Brigande J.V., Heller S. Quo vadis, hair cell regeneration?. Nat. Neurosci. 2009, 12:679-685.
3. Chernajovsky Y., Gould D.J., Podhajcer O.L. Gene therapy for autoimmune diseases: quo vadis?. Nat. Rev. Immunol. 2004, 4:800-811.
4. Chikar J.A., Colesa D.J., Swiderski D.L., Di Polo A., Raphael Y., Pfingst B.E. Over-expression of BDNF by adenovirus with concurrent electrical stimulation improves cochlear implant thresholds and survival of auditory neurons. Hear. Res. 2008, 245:24-34.
5. Coco A., Epp S.B., Fallon J.B., Xu J., Millard R.E., Shepherd R.K. Does cochlear implantation and electrical stimulation affect residual hair cells and spiral ganglion neurons?. Hear. Res. 2007, 225:60-70.
6. Coleman B., Hardman J., Coco A., Epp S., de Silva M., Crook J., Shepherd R. Fate of embryonic stem cells transplanted into the deafened mammalian cochlea. Cell. Transplant. 2006, 15:369-380.
7. Dazert S., Kim D., Luo L., Aletsee C., Garfunkel S., Maciag T., Baird A., Ryan A.F. Focal delivery of fibroblast growth factor-1 by transfected cells induces spiral ganglion neurite targeting in vitro. J. Cell. Physiol. 1998, 177:123-129.
8. Evans A.J., Thompson B.C., Wallace G.G., Millard R., O'Leary S.J., Clark G.M., Shepherd R.K., Richardson R.T. Promoting neurite outgrowth from spiral ganglion neuron explants using polypyrrole/BDNF-coated electrodes. J. Biomed. Mater. Res. A 2009, 91:241-250.
9. Fransson A., Maruyama J., Miller J.M., Ulfendahl M. Post-treatment effects of local GDNF administration to the inner ears of deafened guinea pigs. J. Neurotrauma 2010, 27:1745-1751.
10. Fryer R.H., Kaplan D.R., Kromer L.F. Truncated trkB receptors on nonneuronal cells inhibit BDNF-induced neurite outgrowth in vitro. Exp. Neurol. 1997, 148:616-627.
11. Gillespie L.N., Clark G.M., Bartlett P.F., Marzella P.L. LIF is more potent than BDNF in promoting neurite outgrowth of mammalian auditory neurons in vitro. Neuroreport 2001, 12:275-279.
12. Gillespie L.N., Clark G.M., Bartlett P.F., Marzella P.L. BDNF-induced survival of auditory neurons in vivo: cessation of treatment leads to accelerated loss of survival effects. J. Neurosci. Res. 2003, 71:785-790.
13. Glass D.J., Nye S.H., Hantzopoulos P., Macchi M.J., Squinto S.P., Goldfarb M., Yancopoulos G.D. TrkB mediates BDNF/NT-3-dependent survival and proliferation in fibroblasts lacking the low affinity NGF receptor. Cell 1991, 66:405-413.
14. Glueckert R., Bitsche M., Miller J.M., Zhu Y., Prieskorn D.M., Altschuler R.A., Schrott-Fischer A. Deafferentation-associated changes in afferent and efferent processes in the guinea pig cochlea and afferent regeneration with chronic intrascalar brain-derived neurotrophic factor and acidic fibroblast growth factor. J. Comp. Neurol. 2008, 1:1602-1621.
15. Goren A., Dahan N., Goren E., Baruch L., Machluf M. Encapsulated human mesenchymal stem cells: a unique hypoimmunogenic platform for long-term cellular therapy. FASEB J. 2010, 24:22-31.
16. I within a set range. J. Neurosci. 1997, 17:1959-1970.
17. Huang J., Hu X., Lu L., Ye Z., Zhang Q., Luo Z. Electrical regulation of Schwann cells using conductive polypyrrole/chitosan polymers. J. Biomed. Mater. Res. A 2010, 93:164-174.
18. Ishimoto S., Kawamoto K., Kanzaki S., Raphael Y. Gene transfer into supporting cells of the organ of Corti. Hear. Res. 2002, 173:187-197.
19. Ishimoto S., Kawamoto K., Stöver T., Kanzaki S., Yamasoba T., Raphael Y.A. A glucocorticoid reduces adverse effects of adenovirus vectors in the cochlea. Audiol. Neurootol. 2003, 8:70-79.
20. Izumikawa M., Minoda R., Kawamoto K., Abrashkin K.A., Swiderski D.L., Dolan D.F., Brough D.E., Raphael Y. Auditory hair cell replacement and hearing improvement by Atoh1 gene therapy in deaf mammals. Nat. Med. 2005, 11:271-276.
21. Jerregard H., Akerud P., Arenas E., Hildebrand C. Fibroblast-like cells from rat plantar skin and neurotrophin-transfected 3T3 fibroblasts influence neurite growth from rat sensory neurons in vitro. J. Neurocytol. 2001, 29:653-663.
22. Jiang H., Takeda K., Lazarovici P., Katagiri Y., Yu Z.-X., Dickens G., Chabuk A., Liu X.W., Ferrans V., Guroff G. Nerve growth factor (NGF)-induced calcium influx and intracellular calcium mobilization in 3T3 cells expressing NGF receptors. J. Biol. Chem. 1999, 274:26209-26216.
23. Johnson D.G., Waldron M.J., Frisina R.D., Borkholder D.A. Implantable micropump technologies for murine intracochlear infusions. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2010, 2010:6441-6444.
24. Kanzaki S., Stöver T., Kawamoto K., Prieskorn D.M., Altschuler R.A., Miller J.M., Raphael Y. Glial cell line-derived neurotrophic factor and chronic electrical stimulation prevent VIII cranial nerve degeneration following denervation. J. Comp. Neurol. 2002, 454:350-360.
25. Kho S.T., Pettis R.M., Mhatre A.N., Lalwani A.K. Safety of adeno-associated virus as cochlear gene transfer vector: analysis of distant spread beyond injected cochleae. Mol. Ther. 2000, 2:368-373.
26. Kilpatrick L.A., Li Q., Yang J., Goddard J.C., Fekete D.M., Lang H. Adeno-associated virus-mediated gene delivery into the scala media of the normal and deafened adult mouse ear. Gene Ther. 2011, 18:569-578.
27. Kishino A., Katayama N., Ishige Y., Yamamoto Y., Ogo H., Tatsuno T., Mine T., Noguchi H., Nakayama C. Analysis of effects and pharmacokinetics of subcutaneously administered BDNF. Neuroreport 2001, 12:1067-1072.
28. Lalwani A.K., Han J.J., Castelein C.M., Carvalho G.J., Mhatre A.N. In vitro and in vivo assessment of the ability of adeno-associated virus-brain-derived neurotrophic factor to enhance spiral ganglion cell survival following ototoxic insult. Laryngoscope 2002, 112:1325-1334.
29. Lefebvre P.P., Weber T., Leprince P., Rigo J.-M., Delrée P., Rogister B., Moonen G. Kainate and NMDA toxicity for cultured developing and adult rat spiral ganglion neurons: further evidence for a glutamatergic excitatory neurotransmission at the inner hair cell synapse. Brain Res. 1991, 555:75-83.
30. Lenarz T., Stöver T., Buechner A., Paasche G., Briggs R., Risi F., Pesch J., Battmer R.D. Temporal bone results and hearing preservation with a new straight electrode. Audiol. Neurootol. 2006, 11:34-41.
31. Li H., Xu P., Wang F. The establishment and identification of cell lines with stable expression of human ciliary neurotrophic factor. Chin. Ophthalmic Res. 2002, 20:214-217.
32. Loizou P.C., Mani A., Dorman M.F. Dichotic speech recognition in noise using reduced spectral cues. J. Acoust. Soc. Am. 2003, 114:475-483.
33. Lundberg C., Björklund T., Carlsson T., Jakobsson J., Hantraye P., Déglon N., Kirik D. Applications of lentiviral vectors for biology and gene therapy of neurological disorders. Curr. Gene Ther. 2008, 8:461-473.
34. McCall A.A., Swan E.E., Borenstein J.T., Sewell W.F., Kujawa S.G., McKenna M.J. Drug delivery for treatment of inner ear disease: current state of knowledge. Ear Hear. 2010, 31:156-165.
35. Marzella P.L., Gillespie L.N., Clark G.M., Bartlett P.F., Kilpatrick T.J. The neurotrophins act synergistically with LIF and members of the TGF-beta superfamily to promote the survival of spiral ganglia neurons in vitro. Hear. Res. 1999, 138:73-80.
36. McGuinness S.L., Shepherd R.K. Exogenous BDNF rescues rat spiral ganglion neurons in vivo. Otol. Neurotol. 2005, 26:1064-1072.
37. Miller J.M., Le Prell C.G., Prieskorn D.M., Wys N.L., Altschuler R.A. Delayed neurotrophin treatment following deafness rescues spiral ganglion cells from death and promotes regrowth of auditory nerve peripheral processes: effects of brain-derived neurotrophic factor and fibroblast growth factor. J. Neurosci. Res. 2007, 85:1959-1969.
38. Miller J.M., Chi D.H., O'Keeffe L.J., Kruszka P., Raphael Y., Altschuler R.A. Neurotrophins can enhance spiral ganglion cell survival after inner hair cell loss. Int. J. Dev. Neurosci. 1997, 15:631-643.
39. Nakaizumi T., Kawamoto K., Minoda R., Raphael Y. Adenovirus-mediated expression of brain-derived neurotrophic factor protects spiral neurons from ototoxic damage. Audiol. Neurootol. 2004, 9:135-143.
40. Okano T., Nakagawa T., Kita T., Endo T., Ito J. Cell-gene delivery of brain-derived neurotrophic factor to the mouse inner ear. Mol. Ther. 2006, 14:866-871.
41. Pettingill L.A., Minter R.L., Shepherd R.K. Schwann cells genetically modified to express neurotrophins promote spiral ganglion neuron survival in vitro. Neuroscience 2008, 152:821-828.
42. Pettingill L.N., Wise A.K., Geaney M.S., Shepherd R.K. Enhanced auditory neuron survival following cell-based BDNF treatment in the deaf guinea pig. PLoS One 2011, 15:e18733.
43. Pincha M., Sundarasetty B.S., Stripecke R. Lentiviral vectors for immunization: an inflammatory field. Expert Rev. Vaccines 2010, 9:309-321.
44. Reich U., Mueller P.P., Fadeeva E., Chichkov B.N., Stoever T., Fabian T., Lenarz T., Reuter G. Differential fine-tuning of cochlear implant material-cell interactions by femtosecond laser microstructuring. J. Biomed. Mater. Res. B Appl. Biomater. 2008, 87:146-153.
45. Rejali D., Lee V.A., Abrashkin K.A., Humayun N., Swiderski D.L., Raphael Y. Cochlear implants and ex vivo BDNF gene therapy protect spiral ganglion neurons. Hear. Res. 2007, 228:180-187.
46. Richardson R.T., Wise A.K., Thompson B.C., Flynn B.O., Atkinson P.J., Fretwell N.J., Fallon J.B., Wallace G.G., Shepherd R.K., Clark G.M., O'Leary S.J. Polypyrrole-coated electrodes for the delivery of charge and neurotrophins to cochlear neurons. Biomaterials 2009, 30:2614-2624.
47. Salmon P., Oberholzer J., Occhiodoro T., Morel P., Lou J., Trono D. Reversible immortalization of human primary cells by lentivector-mediated transfer of specific genes. Mol. Ther. 2000, 2:404-414.
48. Salt A.N. Pharmacokinetics of drug entry into cochlear fluids. Volta Rev. 2005, 105:277-298.
49. Salt A.N., Plontke S.K. Local inner-ear drug delivery and pharmacokinetics. Drug Discov. Today 2005, 10:1299-1306.
50. Scheper V., Paasche G., Miller J.M., Warnecke A., Berkingali N., Lenarz T., Stöver T. Effects of delayed treatment with combined GDNF and continuous electrical stimulation on spiral ganglion cell survival in deafened guinea pigs. J. Neurosci. Res. 2009, 87:1389-1399.
51. Shepherd R.K., Coco A., Epp S.B., Crook J.M. Chronic depolarization enhances the trophic effects of brain-derived neurotrophic factor in rescuing auditory neurons following a sensorineural hearing loss. J. Comp. Neurol. 2005, 486:145-158.
52. Shepherd R.K., Coco A., Epp S.B. Neurotrophins and electrical stimulation for protection and repair of spiral ganglion neurons following sensorineural hearing loss. Hear. Res. 2008, 242:100-109.
53. Shibata S.B., Cortez S.R., Beyer L.A., Wiler J.A., Di Polo A., Pfingst B.E., Raphael Y. Transgenic BDNF induces nerve fiber growth into the auditory epithelium in deaf cochleae. Exp. Neurol. 2010, 223:464-472.
54. Shinohara T., Bredberg G., Ulfendahl M., Pyykkö I., Olivius N.P., Kaksonen B., Lindström B., Altschuler R., Miller J.M. Neurotrophic factor intervention restores auditory function in deafened animals. PNAS 2002, 5:1657-1660.
55. Song B.N., Li Y.X., Han D.M. Effects of delayed brain-derived neurotrophic factor application on cochlear pathology and auditory physiology in rats. Chin. Med. J. (Engl.) 2008, 5:1189-1196.
56. Song B.N., Li Y.X., Han D.M. Delayed electrical stimulation and BDNF application following induced deafness in rats. Acta Otolaryngol. 2009, 129:142-154.
57. Spoendlin H. Retrograde degeneration of the cochlear nerve. Acta Otolaryngol. 1975, 79:266-275.
58. Staecker H., Jolly C., Garnham C. Cochlear implantation: an opportunity for drug development. Drug Discov. Today 2010, 15:314-321.
59. Stöver T., Yagi M., Raphael Y. Transduction of the contralateral ear after adenovirus-mediated cochlear gene transfer. Gene Ther. 2000, 7:377-383.
60. Wang J., Li B., Cai C., Zhang Y., Wang S., Hu S., Tian X., Zhang M. Efficient transduction of spiral ganglion neurons in vitro by baculovirus vectors. Neuroreport 2007, 18:1329-1333.
61. Warnecke A., Wissel K., Hoffmann A., Hofmann N., Berkingali N., Groß G., Lenarz T., Stöver T. The biological effects of cell-delivered brain-derived neurotrophic factor on cultured spiral ganglion cells. Neuroreport 2007, 18:1683-1686.
62. Webster M., Webster D.B. Spiral ganglion neuron loss following organ of corti loss: a quantitative study. Brain Res. 1981, 212:17-30.
63. Wefstaedt P., Scheper V., Lenarz T., Stöver T. Brain-derived neurotrophic factor/glial cell line-derived neurotrophic factor survival effects are not limited by dexamethasone. Neuroreport 2005, 16:2011-2014.
64. West B.A., Brummet R.E., Himes D.L. Interaction of kanamycin and ethacrynic acid. Severe cochlear damage in guinea pigs. Arch. Otolaryngol. 1973, 98:32-37.
65. Wise A.K., Hume C.R., O Flynn B., Jeelall Y.S., Suhr C.L., Sgro B.E., O'Leary S.J., Shepherd R.K., Richardson R.T. Effects of localized neurotrophin gene expression on spiral ganglion neuron resprouting in the deafened cochlea. Mol. Ther. 2010, 18:1111-1122.
66. Wissel K., Stöver T., Hofmann N.S., Chernajovsky Y., Daly G., Sasse S., Warnecke A., Lenarz T., Gross G., Hoffmann A. Fibroblast-mediated delivery of GDNF induces neuronal-like outgrowth in PC12 cells. Otol. Neurotol. 2008, 29:475-481.
67. Yagi M., Kanzaki S., Kawamoto K., Shin B., Shah P.P., Magal E., Sheng J., Raphael Y. Spiral ganglion neurons are protected from degeneration by GDNF gene therapy. J. Assoc. Res. Otolaryngol. 2000, 1:315-325.
68. Yamagata T., Miller J.M., Ulfendahl M., Olivius N.P., Altschuler R.A., Pyykkö I., Bredberg G. Delayed neurotrophic treatment preserves nerve survival and electrophysiological responsiveness in neomycin-deafened guinea pigs. J. Neurosci. Res. 2004, 78:75-86.